Global Digital Therapeutics for Psychiatric Illnesses Supply, Demand and Key Producers, 2023-2029
Digital Therapeutics for Psychiatric Illnesses are software program-driven, evidence-based interventions for the treatment, management or prevention of psychiatric illnesses.
This report studies the global Digital Therapeutics for Psychiatric Illnesses demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Digital Therapeutics for Psychiatric Illnesses, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Digital Therapeutics for Psychiatric Illnesses that contribute to its increasing demand across many markets.
The global Digital Therapeutics for Psychiatric Illnesses market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global Digital Therapeutics for Psychiatric Illnesses total market, 2018-2029, (USD Million)
Global Digital Therapeutics for Psychiatric Illnesses total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Digital Therapeutics for Psychiatric Illnesses total market, key domestic companies and share, (USD Million)
Global Digital Therapeutics for Psychiatric Illnesses revenue by player and market share 2018-2023, (USD Million)
Global Digital Therapeutics for Psychiatric Illnesses total market by Type, CAGR, 2018-2029, (USD Million)
Global Digital Therapeutics for Psychiatric Illnesses total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Digital Therapeutics for Psychiatric Illnesses market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, Limbix, Cognoa, Freespira and Shandong Xindao Artificial Intelligence Technology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Digital Therapeutics for Psychiatric Illnesses market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Digital Therapeutics for Psychiatric Illnesses Market, By Region:
1. How big is the global Digital Therapeutics for Psychiatric Illnesses market?
2. What is the demand of the global Digital Therapeutics for Psychiatric Illnesses market?
3. What is the year over year growth of the global Digital Therapeutics for Psychiatric Illnesses market?
4. What is the total value of the global Digital Therapeutics for Psychiatric Illnesses market?
5. Who are the major players in the global Digital Therapeutics for Psychiatric Illnesses market?
6. What are the growth factors driving the market demand?
This report studies the global Digital Therapeutics for Psychiatric Illnesses demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Digital Therapeutics for Psychiatric Illnesses, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Digital Therapeutics for Psychiatric Illnesses that contribute to its increasing demand across many markets.
The global Digital Therapeutics for Psychiatric Illnesses market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global Digital Therapeutics for Psychiatric Illnesses total market, 2018-2029, (USD Million)
Global Digital Therapeutics for Psychiatric Illnesses total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Digital Therapeutics for Psychiatric Illnesses total market, key domestic companies and share, (USD Million)
Global Digital Therapeutics for Psychiatric Illnesses revenue by player and market share 2018-2023, (USD Million)
Global Digital Therapeutics for Psychiatric Illnesses total market by Type, CAGR, 2018-2029, (USD Million)
Global Digital Therapeutics for Psychiatric Illnesses total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Digital Therapeutics for Psychiatric Illnesses market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, Limbix, Cognoa, Freespira and Shandong Xindao Artificial Intelligence Technology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Digital Therapeutics for Psychiatric Illnesses market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Digital Therapeutics for Psychiatric Illnesses Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prevention
- Management
- Treatment
- Insomnia
- Depression
- Autistic
- Anxiety Disorder
- Schizophrenia
- Other
- Pear Therapeutics
- Akili Interactive
- Big Health
- Click Therapeutics
- Orexo
- Limbix
- Cognoa
- Freespira
- Shandong Xindao Artificial Intelligence Technology Co., Ltd.
1. How big is the global Digital Therapeutics for Psychiatric Illnesses market?
2. What is the demand of the global Digital Therapeutics for Psychiatric Illnesses market?
3. What is the year over year growth of the global Digital Therapeutics for Psychiatric Illnesses market?
4. What is the total value of the global Digital Therapeutics for Psychiatric Illnesses market?
5. Who are the major players in the global Digital Therapeutics for Psychiatric Illnesses market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Digital Therapeutics for Psychiatric Illnesses Introduction
1.2 World Digital Therapeutics for Psychiatric Illnesses Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Digital Therapeutics for Psychiatric Illnesses Total Market by Region (by Headquarter Location)
1.3.1 World Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.3 China Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.4 Europe Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.5 Japan Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.6 South Korea Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.7 ASEAN Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.8 India Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Digital Therapeutics for Psychiatric Illnesses Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Digital Therapeutics for Psychiatric Illnesses Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.2 World Digital Therapeutics for Psychiatric Illnesses Consumption Value by Region
2.2.1 World Digital Therapeutics for Psychiatric Illnesses Consumption Value by Region (2018-2023)
2.2.2 World Digital Therapeutics for Psychiatric Illnesses Consumption Value Forecast by Region (2024-2029)
2.3 United States Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.4 China Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.5 Europe Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.6 Japan Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.7 South Korea Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.8 ASEAN Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.9 India Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
3 WORLD DIGITAL THERAPEUTICS FOR PSYCHIATRIC ILLNESSES COMPANIES COMPETITIVE ANALYSIS
3.1 World Digital Therapeutics for Psychiatric Illnesses Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Digital Therapeutics for Psychiatric Illnesses Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Digital Therapeutics for Psychiatric Illnesses in 2022
3.2.3 Global Concentration Ratios (CR8) for Digital Therapeutics for Psychiatric Illnesses in 2022
3.3 Digital Therapeutics for Psychiatric Illnesses Company Evaluation Quadrant
3.4 Digital Therapeutics for Psychiatric Illnesses Market: Overall Company Footprint Analysis
3.4.1 Digital Therapeutics for Psychiatric Illnesses Market: Region Footprint
3.4.2 Digital Therapeutics for Psychiatric Illnesses Market: Company Product Type Footprint
3.4.3 Digital Therapeutics for Psychiatric Illnesses Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Digital Therapeutics for Psychiatric Illnesses Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Digital Therapeutics for Psychiatric Illnesses Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Digital Therapeutics for Psychiatric Illnesses Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Digital Therapeutics for Psychiatric Illnesses Consumption Value Comparison
4.2.1 United States VS China: Digital Therapeutics for Psychiatric Illnesses Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Digital Therapeutics for Psychiatric Illnesses Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Digital Therapeutics for Psychiatric Illnesses Companies and Market Share, 2018-2023
4.3.1 United States Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023)
4.4 China Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue and Market Share, 2018-2023
4.4.1 China Based Digital Therapeutics for Psychiatric Illnesses Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023)
4.5 Rest of World Based Digital Therapeutics for Psychiatric Illnesses Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Digital Therapeutics for Psychiatric Illnesses Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prevention
5.2.2 Management
5.2.3 Treatment
5.3 Market Segment by Type
5.3.1 World Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2018-2023)
5.3.2 World Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2024-2029)
5.3.3 World Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Digital Therapeutics for Psychiatric Illnesses Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Insomnia
6.2.2 Depression
6.2.3 Autistic
6.2.4 Anxiety Disorder
6.2.5 Anxiety Disorder
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2018-2023)
6.3.2 World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2024-2029)
6.3.3 World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pear Therapeutics
7.1.1 Pear Therapeutics Details
7.1.2 Pear Therapeutics Major Business
7.1.3 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product and Services
7.1.4 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pear Therapeutics Recent Developments/Updates
7.1.6 Pear Therapeutics Competitive Strengths & Weaknesses
7.2 Akili Interactive
7.2.1 Akili Interactive Details
7.2.2 Akili Interactive Major Business
7.2.3 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product and Services
7.2.4 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Akili Interactive Recent Developments/Updates
7.2.6 Akili Interactive Competitive Strengths & Weaknesses
7.3 Big Health
7.3.1 Big Health Details
7.3.2 Big Health Major Business
7.3.3 Big Health Digital Therapeutics for Psychiatric Illnesses Product and Services
7.3.4 Big Health Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Big Health Recent Developments/Updates
7.3.6 Big Health Competitive Strengths & Weaknesses
7.4 Click Therapeutics
7.4.1 Click Therapeutics Details
7.4.2 Click Therapeutics Major Business
7.4.3 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product and Services
7.4.4 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Click Therapeutics Recent Developments/Updates
7.4.6 Click Therapeutics Competitive Strengths & Weaknesses
7.5 Orexo
7.5.1 Orexo Details
7.5.2 Orexo Major Business
7.5.3 Orexo Digital Therapeutics for Psychiatric Illnesses Product and Services
7.5.4 Orexo Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Orexo Recent Developments/Updates
7.5.6 Orexo Competitive Strengths & Weaknesses
7.6 Limbix
7.6.1 Limbix Details
7.6.2 Limbix Major Business
7.6.3 Limbix Digital Therapeutics for Psychiatric Illnesses Product and Services
7.6.4 Limbix Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Limbix Recent Developments/Updates
7.6.6 Limbix Competitive Strengths & Weaknesses
7.7 Cognoa
7.7.1 Cognoa Details
7.7.2 Cognoa Major Business
7.7.3 Cognoa Digital Therapeutics for Psychiatric Illnesses Product and Services
7.7.4 Cognoa Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Cognoa Recent Developments/Updates
7.7.6 Cognoa Competitive Strengths & Weaknesses
7.8 Freespira
7.8.1 Freespira Details
7.8.2 Freespira Major Business
7.8.3 Freespira Digital Therapeutics for Psychiatric Illnesses Product and Services
7.8.4 Freespira Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Freespira Recent Developments/Updates
7.8.6 Freespira Competitive Strengths & Weaknesses
7.9 Shandong Xindao Artificial Intelligence Technology Co., Ltd.
7.9.1 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Details
7.9.2 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Major Business
7.9.3 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product and Services
7.9.4 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Recent Developments/Updates
7.9.6 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Digital Therapeutics for Psychiatric Illnesses Industry Chain
8.2 Digital Therapeutics for Psychiatric Illnesses Upstream Analysis
8.3 Digital Therapeutics for Psychiatric Illnesses Midstream Analysis
8.4 Digital Therapeutics for Psychiatric Illnesses Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Digital Therapeutics for Psychiatric Illnesses Introduction
1.2 World Digital Therapeutics for Psychiatric Illnesses Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Digital Therapeutics for Psychiatric Illnesses Total Market by Region (by Headquarter Location)
1.3.1 World Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.3 China Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.4 Europe Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.5 Japan Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.6 South Korea Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.7 ASEAN Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.3.8 India Digital Therapeutics for Psychiatric Illnesses Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Digital Therapeutics for Psychiatric Illnesses Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Digital Therapeutics for Psychiatric Illnesses Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.2 World Digital Therapeutics for Psychiatric Illnesses Consumption Value by Region
2.2.1 World Digital Therapeutics for Psychiatric Illnesses Consumption Value by Region (2018-2023)
2.2.2 World Digital Therapeutics for Psychiatric Illnesses Consumption Value Forecast by Region (2024-2029)
2.3 United States Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.4 China Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.5 Europe Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.6 Japan Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.7 South Korea Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.8 ASEAN Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
2.9 India Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029)
3 WORLD DIGITAL THERAPEUTICS FOR PSYCHIATRIC ILLNESSES COMPANIES COMPETITIVE ANALYSIS
3.1 World Digital Therapeutics for Psychiatric Illnesses Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Digital Therapeutics for Psychiatric Illnesses Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Digital Therapeutics for Psychiatric Illnesses in 2022
3.2.3 Global Concentration Ratios (CR8) for Digital Therapeutics for Psychiatric Illnesses in 2022
3.3 Digital Therapeutics for Psychiatric Illnesses Company Evaluation Quadrant
3.4 Digital Therapeutics for Psychiatric Illnesses Market: Overall Company Footprint Analysis
3.4.1 Digital Therapeutics for Psychiatric Illnesses Market: Region Footprint
3.4.2 Digital Therapeutics for Psychiatric Illnesses Market: Company Product Type Footprint
3.4.3 Digital Therapeutics for Psychiatric Illnesses Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Digital Therapeutics for Psychiatric Illnesses Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Digital Therapeutics for Psychiatric Illnesses Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Digital Therapeutics for Psychiatric Illnesses Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Digital Therapeutics for Psychiatric Illnesses Consumption Value Comparison
4.2.1 United States VS China: Digital Therapeutics for Psychiatric Illnesses Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Digital Therapeutics for Psychiatric Illnesses Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Digital Therapeutics for Psychiatric Illnesses Companies and Market Share, 2018-2023
4.3.1 United States Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023)
4.4 China Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue and Market Share, 2018-2023
4.4.1 China Based Digital Therapeutics for Psychiatric Illnesses Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023)
4.5 Rest of World Based Digital Therapeutics for Psychiatric Illnesses Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Digital Therapeutics for Psychiatric Illnesses Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prevention
5.2.2 Management
5.2.3 Treatment
5.3 Market Segment by Type
5.3.1 World Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2018-2023)
5.3.2 World Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2024-2029)
5.3.3 World Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Digital Therapeutics for Psychiatric Illnesses Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Insomnia
6.2.2 Depression
6.2.3 Autistic
6.2.4 Anxiety Disorder
6.2.5 Anxiety Disorder
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2018-2023)
6.3.2 World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2024-2029)
6.3.3 World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pear Therapeutics
7.1.1 Pear Therapeutics Details
7.1.2 Pear Therapeutics Major Business
7.1.3 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product and Services
7.1.4 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pear Therapeutics Recent Developments/Updates
7.1.6 Pear Therapeutics Competitive Strengths & Weaknesses
7.2 Akili Interactive
7.2.1 Akili Interactive Details
7.2.2 Akili Interactive Major Business
7.2.3 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product and Services
7.2.4 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Akili Interactive Recent Developments/Updates
7.2.6 Akili Interactive Competitive Strengths & Weaknesses
7.3 Big Health
7.3.1 Big Health Details
7.3.2 Big Health Major Business
7.3.3 Big Health Digital Therapeutics for Psychiatric Illnesses Product and Services
7.3.4 Big Health Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Big Health Recent Developments/Updates
7.3.6 Big Health Competitive Strengths & Weaknesses
7.4 Click Therapeutics
7.4.1 Click Therapeutics Details
7.4.2 Click Therapeutics Major Business
7.4.3 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product and Services
7.4.4 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Click Therapeutics Recent Developments/Updates
7.4.6 Click Therapeutics Competitive Strengths & Weaknesses
7.5 Orexo
7.5.1 Orexo Details
7.5.2 Orexo Major Business
7.5.3 Orexo Digital Therapeutics for Psychiatric Illnesses Product and Services
7.5.4 Orexo Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Orexo Recent Developments/Updates
7.5.6 Orexo Competitive Strengths & Weaknesses
7.6 Limbix
7.6.1 Limbix Details
7.6.2 Limbix Major Business
7.6.3 Limbix Digital Therapeutics for Psychiatric Illnesses Product and Services
7.6.4 Limbix Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Limbix Recent Developments/Updates
7.6.6 Limbix Competitive Strengths & Weaknesses
7.7 Cognoa
7.7.1 Cognoa Details
7.7.2 Cognoa Major Business
7.7.3 Cognoa Digital Therapeutics for Psychiatric Illnesses Product and Services
7.7.4 Cognoa Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Cognoa Recent Developments/Updates
7.7.6 Cognoa Competitive Strengths & Weaknesses
7.8 Freespira
7.8.1 Freespira Details
7.8.2 Freespira Major Business
7.8.3 Freespira Digital Therapeutics for Psychiatric Illnesses Product and Services
7.8.4 Freespira Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Freespira Recent Developments/Updates
7.8.6 Freespira Competitive Strengths & Weaknesses
7.9 Shandong Xindao Artificial Intelligence Technology Co., Ltd.
7.9.1 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Details
7.9.2 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Major Business
7.9.3 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product and Services
7.9.4 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Recent Developments/Updates
7.9.6 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Digital Therapeutics for Psychiatric Illnesses Industry Chain
8.2 Digital Therapeutics for Psychiatric Illnesses Upstream Analysis
8.3 Digital Therapeutics for Psychiatric Illnesses Midstream Analysis
8.4 Digital Therapeutics for Psychiatric Illnesses Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Digital Therapeutics for Psychiatric Illnesses Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Digital Therapeutics for Psychiatric Illnesses Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Digital Therapeutics for Psychiatric Illnesses Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Digital Therapeutics for Psychiatric Illnesses Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Digital Therapeutics for Psychiatric Illnesses Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Digital Therapeutics for Psychiatric Illnesses Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Digital Therapeutics for Psychiatric Illnesses Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Digital Therapeutics for Psychiatric Illnesses Players in 2022
Table 12. World Digital Therapeutics for Psychiatric Illnesses Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Digital Therapeutics for Psychiatric Illnesses Company Evaluation Quadrant
Table 14. Head Office of Key Digital Therapeutics for Psychiatric Illnesses Player
Table 15. Digital Therapeutics for Psychiatric Illnesses Market: Company Product Type Footprint
Table 16. Digital Therapeutics for Psychiatric Illnesses Market: Company Product Application Footprint
Table 17. Digital Therapeutics for Psychiatric Illnesses Mergers & Acquisitions Activity
Table 18. United States VS China Digital Therapeutics for Psychiatric Illnesses Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Digital Therapeutics for Psychiatric Illnesses Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (States, Country)
Table 21. United States Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue Market Share (2018-2023)
Table 23. China Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (Province, Country)
Table 24. China Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue Market Share (2018-2023)
Table 26. Rest of World Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue Market Share (2018-2023)
Table 29. World Digital Therapeutics for Psychiatric Illnesses Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2018-2023) & (USD Million)
Table 31. World Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2024-2029) & (USD Million)
Table 32. World Digital Therapeutics for Psychiatric Illnesses Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2018-2023) & (USD Million)
Table 34. World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2024-2029) & (USD Million)
Table 35. Pear Therapeutics Basic Information, Area Served and Competitors
Table 36. Pear Therapeutics Major Business
Table 37. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 38. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pear Therapeutics Recent Developments/Updates
Table 40. Pear Therapeutics Competitive Strengths & Weaknesses
Table 41. Akili Interactive Basic Information, Area Served and Competitors
Table 42. Akili Interactive Major Business
Table 43. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 44. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Akili Interactive Recent Developments/Updates
Table 46. Akili Interactive Competitive Strengths & Weaknesses
Table 47. Big Health Basic Information, Area Served and Competitors
Table 48. Big Health Major Business
Table 49. Big Health Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 50. Big Health Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Big Health Recent Developments/Updates
Table 52. Big Health Competitive Strengths & Weaknesses
Table 53. Click Therapeutics Basic Information, Area Served and Competitors
Table 54. Click Therapeutics Major Business
Table 55. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 56. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Click Therapeutics Recent Developments/Updates
Table 58. Click Therapeutics Competitive Strengths & Weaknesses
Table 59. Orexo Basic Information, Area Served and Competitors
Table 60. Orexo Major Business
Table 61. Orexo Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 62. Orexo Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Orexo Recent Developments/Updates
Table 64. Orexo Competitive Strengths & Weaknesses
Table 65. Limbix Basic Information, Area Served and Competitors
Table 66. Limbix Major Business
Table 67. Limbix Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 68. Limbix Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Limbix Recent Developments/Updates
Table 70. Limbix Competitive Strengths & Weaknesses
Table 71. Cognoa Basic Information, Area Served and Competitors
Table 72. Cognoa Major Business
Table 73. Cognoa Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 74. Cognoa Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Cognoa Recent Developments/Updates
Table 76. Cognoa Competitive Strengths & Weaknesses
Table 77. Freespira Basic Information, Area Served and Competitors
Table 78. Freespira Major Business
Table 79. Freespira Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 80. Freespira Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Freespira Recent Developments/Updates
Table 82. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Basic Information, Area Served and Competitors
Table 83. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Major Business
Table 84. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 85. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Digital Therapeutics for Psychiatric Illnesses Upstream (Raw Materials)
Table 87. Digital Therapeutics for Psychiatric Illnesses Typical Customers
List of Figure
Figure 1. Digital Therapeutics for Psychiatric Illnesses Picture
Figure 2. World Digital Therapeutics for Psychiatric Illnesses Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Digital Therapeutics for Psychiatric Illnesses Total Market Size (2018-2029) & (USD Million)
Figure 4. World Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 13. Digital Therapeutics for Psychiatric Illnesses Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 16. World Digital Therapeutics for Psychiatric Illnesses Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 18. China Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 23. India Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Digital Therapeutics for Psychiatric Illnesses by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Digital Therapeutics for Psychiatric Illnesses Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Digital Therapeutics for Psychiatric Illnesses Markets in 2022
Figure 27. United States VS China: Digital Therapeutics for Psychiatric Illnesses Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Digital Therapeutics for Psychiatric Illnesses Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Digital Therapeutics for Psychiatric Illnesses Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type in 2022
Figure 31. Prevention
Figure 32. Management
Figure 33. Treatment
Figure 34. World Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2018-2029)
Figure 35. World Digital Therapeutics for Psychiatric Illnesses Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application in 2022
Figure 37. Insomnia
Figure 38. Depression
Figure 39. Autistic
Figure 40. Anxiety Disorder
Figure 41. Schizophrenia
Figure 42. Other
Figure 43. Digital Therapeutics for Psychiatric Illnesses Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Table 1. World Digital Therapeutics for Psychiatric Illnesses Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Digital Therapeutics for Psychiatric Illnesses Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Digital Therapeutics for Psychiatric Illnesses Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Digital Therapeutics for Psychiatric Illnesses Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Digital Therapeutics for Psychiatric Illnesses Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Digital Therapeutics for Psychiatric Illnesses Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Digital Therapeutics for Psychiatric Illnesses Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Digital Therapeutics for Psychiatric Illnesses Players in 2022
Table 12. World Digital Therapeutics for Psychiatric Illnesses Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Digital Therapeutics for Psychiatric Illnesses Company Evaluation Quadrant
Table 14. Head Office of Key Digital Therapeutics for Psychiatric Illnesses Player
Table 15. Digital Therapeutics for Psychiatric Illnesses Market: Company Product Type Footprint
Table 16. Digital Therapeutics for Psychiatric Illnesses Market: Company Product Application Footprint
Table 17. Digital Therapeutics for Psychiatric Illnesses Mergers & Acquisitions Activity
Table 18. United States VS China Digital Therapeutics for Psychiatric Illnesses Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Digital Therapeutics for Psychiatric Illnesses Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (States, Country)
Table 21. United States Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue Market Share (2018-2023)
Table 23. China Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (Province, Country)
Table 24. China Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue Market Share (2018-2023)
Table 26. Rest of World Based Digital Therapeutics for Psychiatric Illnesses Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Digital Therapeutics for Psychiatric Illnesses Revenue Market Share (2018-2023)
Table 29. World Digital Therapeutics for Psychiatric Illnesses Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2018-2023) & (USD Million)
Table 31. World Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2024-2029) & (USD Million)
Table 32. World Digital Therapeutics for Psychiatric Illnesses Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2018-2023) & (USD Million)
Table 34. World Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2024-2029) & (USD Million)
Table 35. Pear Therapeutics Basic Information, Area Served and Competitors
Table 36. Pear Therapeutics Major Business
Table 37. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 38. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pear Therapeutics Recent Developments/Updates
Table 40. Pear Therapeutics Competitive Strengths & Weaknesses
Table 41. Akili Interactive Basic Information, Area Served and Competitors
Table 42. Akili Interactive Major Business
Table 43. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 44. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Akili Interactive Recent Developments/Updates
Table 46. Akili Interactive Competitive Strengths & Weaknesses
Table 47. Big Health Basic Information, Area Served and Competitors
Table 48. Big Health Major Business
Table 49. Big Health Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 50. Big Health Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Big Health Recent Developments/Updates
Table 52. Big Health Competitive Strengths & Weaknesses
Table 53. Click Therapeutics Basic Information, Area Served and Competitors
Table 54. Click Therapeutics Major Business
Table 55. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 56. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Click Therapeutics Recent Developments/Updates
Table 58. Click Therapeutics Competitive Strengths & Weaknesses
Table 59. Orexo Basic Information, Area Served and Competitors
Table 60. Orexo Major Business
Table 61. Orexo Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 62. Orexo Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Orexo Recent Developments/Updates
Table 64. Orexo Competitive Strengths & Weaknesses
Table 65. Limbix Basic Information, Area Served and Competitors
Table 66. Limbix Major Business
Table 67. Limbix Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 68. Limbix Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Limbix Recent Developments/Updates
Table 70. Limbix Competitive Strengths & Weaknesses
Table 71. Cognoa Basic Information, Area Served and Competitors
Table 72. Cognoa Major Business
Table 73. Cognoa Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 74. Cognoa Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Cognoa Recent Developments/Updates
Table 76. Cognoa Competitive Strengths & Weaknesses
Table 77. Freespira Basic Information, Area Served and Competitors
Table 78. Freespira Major Business
Table 79. Freespira Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 80. Freespira Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Freespira Recent Developments/Updates
Table 82. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Basic Information, Area Served and Competitors
Table 83. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Major Business
Table 84. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product and Services
Table 85. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Digital Therapeutics for Psychiatric Illnesses Upstream (Raw Materials)
Table 87. Digital Therapeutics for Psychiatric Illnesses Typical Customers
List of Figure
Figure 1. Digital Therapeutics for Psychiatric Illnesses Picture
Figure 2. World Digital Therapeutics for Psychiatric Illnesses Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Digital Therapeutics for Psychiatric Illnesses Total Market Size (2018-2029) & (USD Million)
Figure 4. World Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Digital Therapeutics for Psychiatric Illnesses Revenue (2018-2029) & (USD Million)
Figure 13. Digital Therapeutics for Psychiatric Illnesses Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 16. World Digital Therapeutics for Psychiatric Illnesses Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 18. China Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 23. India Digital Therapeutics for Psychiatric Illnesses Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Digital Therapeutics for Psychiatric Illnesses by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Digital Therapeutics for Psychiatric Illnesses Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Digital Therapeutics for Psychiatric Illnesses Markets in 2022
Figure 27. United States VS China: Digital Therapeutics for Psychiatric Illnesses Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Digital Therapeutics for Psychiatric Illnesses Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Digital Therapeutics for Psychiatric Illnesses Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type in 2022
Figure 31. Prevention
Figure 32. Management
Figure 33. Treatment
Figure 34. World Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2018-2029)
Figure 35. World Digital Therapeutics for Psychiatric Illnesses Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application in 2022
Figure 37. Insomnia
Figure 38. Depression
Figure 39. Autistic
Figure 40. Anxiety Disorder
Figure 41. Schizophrenia
Figure 42. Other
Figure 43. Digital Therapeutics for Psychiatric Illnesses Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
